Zydus Life Sciences Stock Analysis: Undervalued or Overlooked?

Zydus Lifesciences

We recently discussed a company. on our YouTube channel, with a market capitalisation of over ₹1,10,000 crore that earns close to half of its revenue from the United States, and whose stock spent the better part of 18–20 months going nowhere. On a price-to-earnings basis it had drifted down to a meaningful discount to its […]

Beacon Trusteeship: Riding India’s Debt Market Expansion

Beacon Trusteeship

Every corporate debt and every alternative fund launched in India needs a SEBI-licensed trustee to legally exist. Beacon Trusteeship is the only listed pure-play on that mandatory toll – a capital-light, recurring-revenue franchise growing earnings at a 5-year CAGR of 44%. Since Trusteeship is an asset-light model that throw off cash. Trusteeship needs negligible capital – the model […]

How Freshara Is Moving Up the Global Food Value Chain

Freshara Investment thesis

Incorporated in 2015, Freshara Agro Exports Ltd is a producer and exporter of preserved gherkins and related products, Freshara  specializes in procurement, processing, and exporting preserved gherkins and pickled vegetables. Its products are certified by FSSAI, FDA, Star-K Kosher, APEDA, IFS, and BRCGS, meeting international quality standards The “local” Arbitrage Industry Analysis: The Global Pickle […]

Rashi Peripherals: Here’s What the Market Is Missing

Rashi Peripheral Investment Thesis

THE SNAPSHOT- Rashi Peripherals CMP ₹518 Market Cap ₹3,414 Cr P/E (TTM) 14x P/B 1.84x Revenue (TTM) ₹14,311 Cr PAT (TTM) ₹248 Cr ROE / ROCE 12.5% / 14.2% 52W H/L ₹547 / ₹275 5Y Sales CAGR 28.5% 5Y PAT CAGR 39.4% Promoter holding 64.0% Net Debt/Equity 0.5x  Rashi Peripherals (RP Tech) is the largest […]

Senco Gold vs Titan: Same Industry, One-Sixth the Multiple

Senco Gold Investment thesis

THE SNAPSHOT CMP ₹326 Market Cap ₹5,129 Cr P/E (TTM) ~10.6x P/B 2.41x Revenue (TTM) ₹7,773 Cr PAT (TTM) ₹485 Cr 52W H/L ₹406 / ₹276 Promoter Holding 64.5% Stores (Mar-26) 201 FY26 Rev growth +35%   Senco is the largest organised jewellery retailer in Eastern India. Founded in 1938, listed in 2023, it runs […]

Innova Captab: Stock Analysis

Innova Captab Investment thesis

THE SNAPSHOT-Innova Captab CMP ₹752 Market Cap ₹4,304 Cr P/E (TTM) 32x Book Value ₹178 ROE / ROCE 14.3% / 14.6% 52W H/L ₹1,021 / ₹608 5Y Sales CAGR 27% 5Y PAT CAGR 36% Stock has corrected ~26% from 52W high while earnings power is still building – that gap is what this thesis explores. […]

KMC Speciality Hospitals- Stock Analysis

KMC Speciality Hospitals

Most investors looking at Indian hospital stocks instinctively reach for Apollo, Max, Fortis, or Narayana. KMC Speciality Hospitals doesn’t make that list. It’s a sub-₹1,500 Cr market-cap small-cap that operates exactly one hospital – a 450-bed multi-specialty facility in Tiruchirapalli (Trichy), Tamil Nadu – and yet has compounded into one of the more interesting under-the-radar […]

Ceinsys Tech: Picks and Shovels for Digital India

Ceinsys Tech

Some businesses look boring on the surface and stay boring. Others look boring and quietly turn into compounding machines because they sit at the intersection of multiple structural tailwinds. Ceinsys Tech — now rebranded CS Tech AI — belongs in the second bucket, but the price action over the past year tells you the market […]

Interarch: The Steel Spine of India’s Next Decade of Capex

Interarch Building Solutions

Interarch is a mid-cycle, asset-light, net-cash, capital-efficient proxy for the structural shift of Indian construction from concrete to engineered steel — specifically in the pockets where that shift is most economic (data centres, fabs, gigafactories, large warehouses). It’s the #2 player in an industry where the top seven are taking share from an unorganised tail […]

Windlas Biotech: CDMO Compounder Hiding in Plain Sight

Windlas Biotech

Everyone wants to own the next Cipla or Sun Pharma. Nobody wants to own the company that actually makes the pills those brands sell. That’s exactly why Windlas Biotech is interesting. At ₹867 (April 17, 2026), the stock sits ~24% below its 52-week high of ₹1,140, trading at ~27x trailing earnings, a ~3.4x price-to-book, and […]